A detailed history of American National Bank transactions in Dexcom Inc stock. As of the latest transaction made, American National Bank holds 485 shares of DXCM stock, worth $42,718. This represents 0.0% of its overall portfolio holdings.

Number of Shares
485
Holding current value
$42,718
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025

BUY
$65.68 - $81.01 $31,854 - $39,289
485 New
485 $37,000
Q3 2022

Oct 05, 2022

BUY
$76.35 - $94.18 $1,527 - $1,883
20 New
20 $9,000
Q2 2022

Jul 11, 2022

SELL
$67.99 - $132.89 $6,187 - $12,092
-91 Closed
0 $0
Q1 2022

Apr 08, 2022

BUY
$94.08 - $130.2 $2,163 - $2,994
23 Added 33.82%
91 $47,000
Q4 2021

Feb 09, 2022

BUY
$129.87 - $162.82 $8,831 - $11,071
68 New
68 $37,000
Q2 2021

Jul 12, 2021

SELL
$80.99 - $107.93 $890 - $1,187
-11 Closed
0 $0
Q1 2021

Apr 09, 2021

BUY
$84.79 - $104.74 $932 - $1,152
11 New
11 $4,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $34B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track American National Bank Portfolio

Follow American National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American National Bank, based on Form 13F filings with the SEC.

News

Stay updated on American National Bank with notifications on news.